Ionis Pharmaceuticals IONS Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's net change in cash?
- Ionis Pharmaceuticals (IONS) reported net change in cash of -$198.88M in Q1 2026.
- How has Ionis Pharmaceuticals's net change in cash changed year-over-year?
- Ionis Pharmaceuticals's net change in cash decreased by 999.3% year-over-year, from $22.12M to -$198.88M.
- What is the long-term trend for Ionis Pharmaceuticals's net change in cash?
- Over 3 years (2021 to 2025), Ionis Pharmaceuticals's net change in cash has grown at a -34.9% compound annual growth rate (CAGR), from $471.53M to $130.18M.
- What does net change in cash mean?
- The total change in the company's cash balance over the period.
- How do you interpret net change in cash?
- A positive change indicates net cash generation, while a negative change indicates cash burn.
- How does net change in cash compare across companies?
- A fundamental liquidity metric used to assess overall cash flow sustainability.